Latent Classes of Nicotine Beliefs Correlate with Perceived Susceptibility and Severity of Nicotine and Tobacco Products in US young adults.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
23 12 2019
Historique:
received: 11 05 2019
accepted: 21 08 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 2 5 2020
Statut: ppublish

Résumé

Pervasive misperceptions about nicotine may influence uptake of quit smoking aids and the impact of policies addressing nicotine as a tobacco product constituent. Latent class analyses were conducted using four items on nicotine beliefs asked of 4037 adults aged 18-40 in wave 9 (February-March 2016) of the Truth Initiative Young Adult Cohort Study. Confirmatory factor analyses identified three factors from 12 items: nicotine susceptibility (NSUS), nicotine severity (NSEV), and tobacco severity (TSEV). Analyses assessed correlations between latent classes, sociodemographics, and nicotine/tobacco factor scores. A four-class model of nicotine beliefs was the best fit, with the largest class believing that nicotine plays a major part in smoking risks (class 1, n = 2070; 52%). Class 2 shared that belief but also responded "Don't know" to addiction questions (class 2, n = 382; 11%). Fewer belonged in class 3, who reported that nicotine plays a small part in health risks (n = 1277; 30%), and class 4, who perceived nicotine as not cancer causing (n = 308; 7%). Latent class membership was correlated with sociodemographics, peer smoking, and past 30-day tobacco use. Classes 1 and 2 had similar NSUS scores and classes 3 and 4 had similar NSEV and TSEV scores. Differences in the perceptions of nicotine and tobacco-related harms can be partially explained by clustering of underlying nicotine beliefs. These classes of beliefs are correlated with sociodemographic predictors of smoking. These findings may help to identify specific beliefs or groups to be targeted by public education efforts on nicotine. The current study supports that underlying nicotine beliefs are associated with perceived harms of specific nicotine and tobacco products (relative to cigarettes), with greater false beliefs about nicotine correlated with greater perceived susceptibility to nicotine addiction. Two important inferences emerge from this study: first, that education to address nicotine beliefs may also reframe perceptions of the harms of nicotine and tobacco products; and second, that this type of education may differentially impact perceptions of the harms of nicotine products (e.g., nicotine replacement therapy and e-cigarettes) and tobacco products (e.g., cigars, smokeless, and hookah).

Sections du résumé

BACKGROUND
Pervasive misperceptions about nicotine may influence uptake of quit smoking aids and the impact of policies addressing nicotine as a tobacco product constituent.
METHODS
Latent class analyses were conducted using four items on nicotine beliefs asked of 4037 adults aged 18-40 in wave 9 (February-March 2016) of the Truth Initiative Young Adult Cohort Study. Confirmatory factor analyses identified three factors from 12 items: nicotine susceptibility (NSUS), nicotine severity (NSEV), and tobacco severity (TSEV). Analyses assessed correlations between latent classes, sociodemographics, and nicotine/tobacco factor scores.
RESULTS
A four-class model of nicotine beliefs was the best fit, with the largest class believing that nicotine plays a major part in smoking risks (class 1, n = 2070; 52%). Class 2 shared that belief but also responded "Don't know" to addiction questions (class 2, n = 382; 11%). Fewer belonged in class 3, who reported that nicotine plays a small part in health risks (n = 1277; 30%), and class 4, who perceived nicotine as not cancer causing (n = 308; 7%). Latent class membership was correlated with sociodemographics, peer smoking, and past 30-day tobacco use. Classes 1 and 2 had similar NSUS scores and classes 3 and 4 had similar NSEV and TSEV scores.
DISCUSSION
Differences in the perceptions of nicotine and tobacco-related harms can be partially explained by clustering of underlying nicotine beliefs. These classes of beliefs are correlated with sociodemographic predictors of smoking. These findings may help to identify specific beliefs or groups to be targeted by public education efforts on nicotine.
IMPLICATIONS
The current study supports that underlying nicotine beliefs are associated with perceived harms of specific nicotine and tobacco products (relative to cigarettes), with greater false beliefs about nicotine correlated with greater perceived susceptibility to nicotine addiction. Two important inferences emerge from this study: first, that education to address nicotine beliefs may also reframe perceptions of the harms of nicotine and tobacco products; and second, that this type of education may differentially impact perceptions of the harms of nicotine products (e.g., nicotine replacement therapy and e-cigarettes) and tobacco products (e.g., cigars, smokeless, and hookah).

Identifiants

pubmed: 31867640
pii: 5684941
doi: 10.1093/ntr/ntz156
pmc: PMC6939776
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

S91-S100

Subventions

Organisme : NCI NIH HHS
ID : R03 CA212694
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

Références

Health Psychol. 2007 Mar;26(2):136-45
pubmed: 17385964
Addict Behav. 2019 Nov;98:106020
pubmed: 31238235
J Adolesc Health. 2018 Nov;63(5):582-586
pubmed: 30348280
Prev Med. 2017 Nov;104:63-70
pubmed: 28647547
Subst Use Misuse. 1998 Mar;33(4):995-1026
pubmed: 9548633
Tob Control. 2018 Nov;27(6):712-714
pubmed: 29363610
JAMA Intern Med. 2013 Jul 8;173(13):1215-21
pubmed: 23712194
Curr Opin Psychol. 2015 Oct 1;5:85-89
pubmed: 26258160
Addict Behav. 2019 Apr;91:180-187
pubmed: 30502927
JAMA Intern Med. 2013 Oct 28;173(19):1798-806
pubmed: 23958803
Am J Public Health. 2012 Jan;102(1):134-40
pubmed: 22095353
Prev Med. 2017 Mar;96:94-100
pubmed: 28034733
Addict Behav. 2019 Apr;91:171-174
pubmed: 30501991
Subst Use Misuse. 1999 Jun;34(7):947-82
pubmed: 10359215
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Health Psychol. 2012 Jul;31(4):467-75
pubmed: 22775236
Health Educ Behav. 2016 Jun;43(3):328-36
pubmed: 26304709
J Clin Oncol. 2015 Apr 1;33(10):1143-50
pubmed: 25732156
J Public Health Manag Pract. 2017 Sep/Oct;23(5):487-495
pubmed: 27798530
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538
pubmed: 23193840
IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592
pubmed: 18335640
Addict Behav. 2017 Jul;70:83-89
pubmed: 28214741
Annu Rev Public Health. 2018 Apr 1;39:193-213
pubmed: 29323611
Am J Prev Med. 2014 Aug;47(2):141-9
pubmed: 24794422
Ann Behav Med. 2004 Apr;27(2):125-30
pubmed: 15026296
Drug Alcohol Depend. 2018 Sep 1;190:1-5
pubmed: 29958115
J Environ Public Health. 2012;2012:679134
pubmed: 22666279
JAMA Netw Open. 2019 Mar 1;2(3):e191047
pubmed: 30924893
Am J Prev Med. 2014 Aug;47(2 Suppl 1):S53-60
pubmed: 25044196
Subst Use Misuse. 2015 Jan;50(1):79-89
pubmed: 25268294
Am J Prev Med. 2019 Oct;57(4):e135-e142
pubmed: 31542145

Auteurs

Andrea C Villanti (AC)

Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, VT.

Shelly Naud (S)

Department of Medical Biostatistics, University of Vermont, Burlington, VT.

Julia C West (JC)

Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, VT.

Jennifer L Pearson (JL)

Division of Social and Behavioral Sciences/Health Administration and Policy, School of Community Health Sciences, University of Nevada, Reno, Reno, NV.

Olivia A Wackowski (OA)

Center for Tobacco Studies, Rutgers School of Public Health, State University of New Jersey, New Brunswick, NJ.

Elizabeth Hair (E)

Schroeder Institute at Truth Initiative, Washington, DC.

Jessica M Rath (JM)

Schroeder Institute at Truth Initiative, Washington, DC.

Raymond S Niaura (RS)

Department of Social and Behavioral Sciences, College of Global Public Health, New York University, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH